Product Information

LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $3.4421 per EA under NDC 42192062328. Its NADAC has been published 140 times since Dec 20, 2023.

FDA first approved this application on Jan 9, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the levonorgestrel and ethinyl estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB

levonorgestrel and ethinyl estradiol
$3.4421per EA
High Outlier

NDC

42192062328

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA208612

FDA Approved

1/9/2018

TE Code

AB3

On Market Since

8/21/2023

Price Statistics

The NADAC for LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB has been published 140 times since Dec 20, 2023, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.

Current price$3.4421 per EA
All-time high$8.2737 (Apr 10, 2024)
All-time low$3.4240 (Jul 22, 2026)
52-week high$5.2480
52-week low$3.4240
Median price$5.3936
Average price$5.6253
Largest weekly change-15.2% (May 22, 2024)
Weeks tracked140
Tracking sinceDec 20, 2023

Price History

1W

+0.5%

1M

+0.5%

3M

-14.6%

6M

-33.5%

1Y

-34.4%

3Y

N/A

5Y

N/A

All

-58.4%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB, manufactured by Acella Pharmaceuticals, LLC, is $3.4421 per EA (NDC 42192062328), effective Aug 19, 2026.

How has the price of LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB has declined 58.4%. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.

What are the highest and lowest recorded NADAC prices for LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB?

Since Dec 20, 2023, the NADAC for LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB has ranged from a low of $3.4240 (Jul 22, 2026) to a high of $8.2737 (Apr 10, 2024), with a median of $5.3936 per EA.

Are there cheaper alternatives to LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KURVELO-28 TABLET, is $0.1128 per EA — about 97% below LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB.

Who manufactures LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB?

LEVONORGESTREL-ETH ESTRADIOL-FE BISGLYC 0.1-0.02-36.5 MG TAB (NDC 42192062328) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.